iProov is working with enterprises and governments around the world to verify citizen and customer identity online. Our biometric authentication technology enables simple, secure access to digital services.
iProov biometric technology enabling users in England to create their NHS login remotely, securely and conveniently at a time when they need it most, removing the need for manual and in-person verifications.
iProov is developing technology to enhance cross-border passenger travel at unmanned ports of entries while reducing processing time.
iProov is providing facial authentication technology to Dutch challenger bank Knab to provide an effortless online biometric experience to its nearly 500,000 customers.
iProov supported the world’s largest and most successful digital on-boarding program for immigration, using Genuine Presence Assurance®. Over 3 million EUSS applicants granted status up to the end of March 2020.
Rail passengers using Eurostar services will be the first to take advantage of a facial biometric corridor, facilitated by iProov, to enable contactless journeys.
iProov is working with InnoValor on an onboarding project for Rabobank, one of the 50 largest banks in the world. The new solution allows customers to open a bank account using their smartphones.
Four million Singapore residents can now prove that they are genuinely present when accessing online government services on mobile devices or at kiosks. The National Digital Identity (NDI) platform has also been extended to commercial enterprises.
Since 2014, Estonia has earned a global reputation for pioneering the provision and use of digital identities for its citizens. The Smart-ID service from SK ID now allows Estonians to renew a Smart-ID account without having to visit a bank branch.
bloomd is a digital community that facilitates an intergenerational exchange of knowledge, experience and companionship in a fun and safe way. iProov biometric authentication acts as a ‘virtual doorkeeper’ to reduce the risk of repeat trolling or fraudulent behavior.